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Human regulatory CD4+CD25+FOXP3+ T cells (Treg) play important roles in the
maintenance of self-tolerance and immune homeostasis in various disease settings and
are also involved in the suppression of effective immune responses. These cells are
heterogeneous in phenotype and function, and the ability to reliably distinguish between
various FOXP3-expressing subpopulations can affect the development of successful
therapies. This study demonstrates that hypomethylated CpG sites, present in four
regions of the FOXP3 locus,CAMTA1 and FUT7 gene regions, can be used to distinguish
several subsets of Treg from conventional CD4+ T lymphocytes (Tcon) in donors of both
genders. We describe a previously unreported strand-bias hemimethylation pattern in
FOXP3 promoter and TSDR in donors of both genders, with the coding strand being
demethylated within promoter and methylated within TSDR in all CD4+ lymphocyte
subtypes, whereas the template strand follows the previously described pattern of
methylation with both regions being more demethylated in Treg subtypes and mostly
methylated in Tcon. This strand-specific approach within the TSDR may prove to be
instrumental in correctly defining Treg subsets in health and in disease.
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INTRODUCTION
Regulatory T cells (Treg) play crucial roles in the maintenance of self-tolerance and immune
homeostasis in diseases such as allergy and autoimmune disorders (AID). These cells are also
involved in the suppression of effective immune responses against invading pathogens and
autologous cancerous cells (1, 2). Human CD4+CD25+FOXP3+ T cells are heterogeneous in
phenotype and function and include resting (rTreg) and activated (aTreg) Treg cells, as well as
non-suppressive Treg-like cells (3, 4). Despite this, for many years FOXP3 expression alone has
been used as a specific Treg marker until it was deemed insufficient for identification of suppressive
Treg cells. The ability to reliably distinguish between various FOXP3-expressing subpopulations
and to understand their roles in immunological diseases, cancer and infections can foster therapies
that either aim to boost the suppressed immune responses or to dampen the abnormally acute
immune responses.
Toward this goal, Miyara et al. (5) used the combination of CD25 and CD45RA for
isolating three human Treg subsets: FOXP3lowCD45RA+CD25++ suppressive in vitro rTreg,
FOXP3hiCD45RA−CD25+++ effector (eTreg) cells and cytokine-secreting non-suppressive
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FOXP3lowCD45RA−CD25++ T cells. Later, CD15s (sialyl
Lewis x) was identified as a biomarker of most suppressive
FOXP3high eTreg cells (6). A combination of CD15s and
CD45RA was instrumental in the isolation of distinct
CD4+CD127lowCD25+FOXP3+ T cell subtypes: naïve
CD45RA+CD15s− Treg, highly suppressive CD45RA−CD15s+
eTreg and a non-suppressive CD45RA−CD15s− subset.
Together with histone acetylation and non-coding RNAs,
DNA methylation can either stably or temporarily alter
gene expression depending on the immediate physiological
requirements of the organism. Several regulatory regions
on FOXP3 locus are very important players in the Treg-
specific epigenome: two conserved non-coding sequences (CNS
1 and 3) are involved in histone acetylation while three
other regions - upstream enhancer, proximal promoter and
CNS 2 (known as FOXP3 TSDR) contribute to FOXP3
expression via demethylation and were proposed as additional
molecular markers that can help distinguish Treg from
conventional T lymphocytes (Tcon), as well as different
Treg maturation stages (7–9). At the same time, changes
in T cell DNA methylation patterns have been reported in
diseases such as allergies, multiple sclerosis and rheumatoid
arthritis (10, 11). However, as FOXP3 gene is encoded on
Xp11.23, most studies opted to use male donors in order
to avoid the artifacts of the inactivation of X chromosome
(Xi). Therefore, precise regulation of FOXP3 expression in
female donors remains somewhat of an enigma—yet females
comprise the majority of patients with AID and show
a stronger response to infections than males. CAMTA1,
encoded on chromosome 1q3.6 and not affected by Xi,
was able to differentiate CD25highCD45RA−CD4+ Treg from
CD25−CD45RA+CD4+ Tcon (7) and, therefore, has the
potential to distinguish T cell subsets in both male and female
donors.
In this study, we characterized the epigenetic profile of
hematopoietic stem cells (CD34+) and four populations of
CD4+CD25+ T cells: CD45RA+CD15s− FOXP3low (naïve
nTregs), CD45RA−15s−FOXP3low (non-suppressive Treg-like
cells), CD45RA−CD15s+FOXP3high (eTregs) and Tcons isolated
from peripheral blood of healthy male and female donors. As
α(1, 3)-fucosyltransferase 7 (FUT7) mediates synthesis of CD15s
expressed in both eTregs and CD34+ cells (12), FUT7 promoter
was expected to be demethylated in these cell populations to allow
for protein expression. Together withCAMTA1 intronic region 3,
FUT7 promoter was tested for its potential to act as an additional
and/or alternative to FOXP3molecular marker. Three previously
described regions on FOXP3 locus: upstream enhancer, proximal
promoter and TSDR (Treg-specific demethylated region), were
also studied together with the fourth region, that we now term
preTSDR. As DNA methylation was shown to vary among
individuals and even between twins (13, 14), we attempted to
characterize epigenetic changes in all six gene regions from
the five cell populations of each donor in order to obtain
comprehensive information specific of each individual. Using
bisulphite conversion of genomic DNA (gDNA) followed by
sequencing of individual clones was instrumental in deciphering
the methylation status of individual CpG positions and the
intricate patterns controlling gene expression in CD34+ cells and
T lymphocyte subsets.
MATERIALS AND METHODS
Isolation of Human PBMCs and Flow
Cytometry
Peripheral blood samples were obtained from young healthymale
(M1-6) and female (F1-5) volunteers. None of the donors had
known autoimmune or genetic conditions.
Peripheral blood mononuclear cells (PBMCs) were prepared
by Ficoll gradient centrifugation (15). CD34+ cells (donors
M4-6 and F1-5) were first enriched using the EasySepTM
Human CD34 Positive Selection kit (STEMCELL Technologies)
following the manufacturer’s instructions. In order to increase
the purity of the magnetically isolated CD34+ fraction, the
cells were further stained with CD34 FITC (Miltenyi Biotec)
and sorted by fluorescent activated cell sorting (FACS) on a
BD FACSAriaIII. Tcon and Treg subpopulations were purified
from the negative fraction obtained from the EasySepTM
CD34 selection protocol as follows: cells were incubated for
25min at room temperature in PBS (2% human serum)
with pre-titrated amounts of the following antibodies: anti-
hCD3 (-PerCP, clone OKT3, eBioscience), anti-hCD4 (-APC,
clone RPA-T4, eBioscience), anti-hCD45RA (-FITC, Miltenyl
Biotec), anti-hCD25 (-Pe-Cy7, BD Biosciences), anti-hCD127
(-APCe780, clone eBioRDR5, eBioscience), anti-hCD15s (-
PE, BD Biosciences). Cells were then washed and sorted on
a BD FACSAriaIII. Cells obtained from the EasySep CD34
negative fraction were further used for intracellular staining
for FOXP3. Following the surface staining using the same
antibody combination as described above for cell sorting, cells
were stained with anti-hFOXP3 (eFluor450, clone PCH101,
eBioscience) using the FOXP3 Staining Buffer Set (e-Bioscience)
according to the manufacturer’s instructions. Data was acquired
on the BD FACSAriaIIu. For analysis of CD34+ cells, whole
blood samples were surface stained for 20min at room
temperature with the same antibodies as above except for anti-
hCD4 (PerCPCy5.5, clone OKT4, eBioscience), anti-hCD45RA
(APC, clone T6D11, Miltenyl Biotec), anti-hCD3 (BV510,
cloneUCHT1, BD Horizon). Intracellular staining for FOXP3
(eFluor450, clone PCH101, eBioscience) was performed using
RBC lysis, fixation and permeabilization reagents (eBioscience),
according to the manufacturer’s instructions. Samples were
acquired on a BD LSR Fortessa flow cytometer (BD Biosciences).
Data were analyzed using FlowJo R© LLC.
Isolation of Genomic DNA
gDNA from CD34+ cells and four populations of CD4+ T
cells were isolated by the Quick-gDNA MiniPrep kit (Zymo
Research) following manufacturer’s instructions. Briefly, cells
were resuspended in 100 µl of PBS then lysed in 400 µl
of Genomic Lysis Buffer for 10min. Sample was loaded into
provided Zymo-Spin column and centrifuged at 10,000 g for
1min. The column was then washed in two steps: (i) 200 µl of
DNA Pre-Wash Buffer and (ii) 500 µl of gDNA Wash Buffer.
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gDNA was eluted from the column in 45 µl of DNA Elution
Buffer.
Bisulphite Treatment and Methylation
Analysis
Determination of methylation status of individual CpG sites
across entire amplicons can be achieved by BS treatment
of gDNA followed by sequencing of individual clones, each
representing one DNA molecule from one cell in a given
cell population. The fact that BS treatment converts all non-
methylated cytosines (C) into uracils (U) while methylated Cs
(mC) remain unchanged means that the two DNA strands in
BS DNA are no longer complementary. Only one strand of
BS DNA is amplified by each primer set, with the reverse
primer binding the chosen target strand and the resulting
amplified strand serving as a template for the forward primer.
In addition to strand-specificity, primers are designed in such
a way that biased amplification of non-methylated strands is
avoided and only BS DNA is amplified. To avoid any potential
bias affecting the downstream sequencing results, gDNA from the
five cell populations: CD34+, CD45RA+15s−, CD45RA−15s−,
CD45RA−15s+, and Tcons, was isolated and BS treated at the
same time followed by BS PCR and cloning of the six gene
regions.
Conversion of gDNA from the five cell populations was
performed by EZ DNA Methylation Lightning Kit (Zymo
Research) which results in over 99.5% C to U conversion of
non-methylated residues while over 99.5% of mC are protected.
Briefly, 130 µl of Lightning Conversion Reagent was added to
20 µl of gDNA and the samples were incubated at 95◦C for
8min followed by 54◦C for 60min. DNA samples were loaded
into Zymo-Spin IC Columns containing 600 µl of M-Binding
Buffer, mixed well and centrifuged at 10,000 g for 30 s (as all
other centrifugation steps). Following the first wash step with
100 µl of M-Wash Buffer, the samples were incubated with 200
µl of M-Desulphonation Buffer at room temperature for 15min.
Columns were washed twice with 200 µl of M-Wash Buffer.
Converted BS-treated DNA was eluted in 12 µl of M-Elution
buffer and immediately used for PCR analyses. Remaining BS-
treated DNA was stored at−20◦C for later use.
The six gene regions were amplified using non-
methylation-, BS-treated DNA-, coding strand-specific primers
(Supplementary Table 1). Thirty PCR reactions for the six gene
regions were performed in parallel containing 1.5 µl of BS DNA
and Phusion U Hot Start PCR mix (Thermo Fisher Scientific)
in a total volume of 25 µl. After initial denaturation at 98◦C
for 30 s, amplification consisted of 45 cycles at 98◦C for 10 s,
58-60◦C for 20 s, and 72◦C for 45 s. The PCR products obtained
were gel purified using NZYGelpure kit (NZYtech) following the
manufacturer’s instructions and cloned into the pGEM-T Easy
vector (Promega) via NcoI and NsiI restriction sites to ensure
directional cloning. Plasmid DNAs from 22–24 clones were
isolated using plasmid NZYMiniprep kit (NZYtech) and 20–22
positive clones (unless otherwise stated), confirmed by restriction
digestion with the above-mentioned enzymes, were sequenced
using reverse SP6 primer: 5′-GTGACACTATAGAATACTC-3′
(NZY sequencing and Stabvida). Sequences (AB1 files containing
chromatograms) were aligned to each gene region’s reference
sequence using SeqMan software (DNA Star Lasergene 8). All
non-methylated cytosines were identified by the presence of a
T nucleotide (nt) in BS-converted sequences while mCs were
identified by the presence of a C nt. Efficiency of bisulphite
conversion was confirmed by conversion of non-CpG Cs to
Ts. The percentage of methylation in each CpG position was
determined by defining the proportion of mCs in the total of
20 (2 mCs out of 20=10% methylation). As the six gene regions
were amplified from the same BS DNA template, the methylation
differences reflect the average methylation status of the cell
population.
Statistical Analysis
To analyze the differences in methylation between Tcon and the
three Treg populations (CD45RA+CD15s−, CD45RA−CD15s−,
and CD45RA− CD15s+) for the six genes studied, we used
a mixed-effects approach, taking into consideration the paired
nature of the data. For each gene, the difference in methylation
values between Tcon and each of the Treg populations was
calculated and then this difference was tested for significant
differences from zero (indicating a difference in methylation
between the two populations being compared), with individual
and CpG position considered as random effects. This analysis
was done using the function lme from the package nlme of
R (https://cran.r-project.org/). Since in each case we used the
methylation of Tcon for three tests, we corrected for multiple
comparisons and only considered as significant those results with
p< 0.016 (equivalent to α= 0.05/3). We used the same approach
to compare the methylation of the top and bottom strands.
Hierarchical Clustering
Hierarchical Agglomerative Clustering was performed using
Euclidean distance matrix and complete linkage algorithm.
Distance matrix was calculated on average methylation for each
CpG position across all donors for each genomic element.
Heatmap package in R was used to generate heatmaps (16).
Study Approval
Ethical approval by the institution’s Ethics Committee was
received prior to the beginning of the study. Written informed
consent was received from participants prior to inclusion in the
study.
RESULTS
Isolation of CD34+ and CD4+ T Cell
Subpopulations
Cell populations were isolated from the peripheral blood of
healthy donors by FACSorting. The mean purity of CD34+
cells after FACSort was >95%, as shown in a representative
dot plot in Figure 1A. Treg and Tcon cells were identified as
CD3+CD4+CD25BrightCD127Low and CD3+CD4+CD25Low
cells, respectively. Treg cells were further purified into the
following subpopulations: CD45RA+CD15s− (naïve Treg),
CD45RA−CD15s− (non-suppressive Treg-like cells) and
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FIGURE 1 | Flow cytometry analysis and purification strategy of Treg, Tcon, and CD34 cell populations. (A) Purity of CD34+ cells after FACSorting. Representative dot
plot showing the frequency of CD34+ cells within a live cell gate, as determined by FSC and SSC analysis. (B) Representative dot plots showing the gating strategy
for the isolation of Treg and Tcon cells by FACSort. Firstly, FSC and SSC analysis was used to identify lymphocytes and to exclude doublets. Treg cells were isolated
as CD3+CD4+CD25BrightCD127Low and Tcon as CD3+CD4+CD25Low cells. Treg were further gated into CD45RA+CD15s− (naïve Treg), CD45RA−CD15s−
(non-suppressive Treg-like cells), and CD45RA−CD15s+ (eTreg). (C) Representative dot plots showing the purity obtained for each T cell population after FACSort.
(D) FoxP3 expression levels within CD45RA/CD15s Treg subpopulations, as well as within naïve Tcon cells. A representative overlay of Foxp3 expression within these
T cell populations is shown. (E) Median Fluorescence Intensity (MFI) of FoxP3 within Treg subpopulations for all individuals analyzed. Asterisks denote statistically
significant differences between groups (*p = 0.01–0.05; ****p < 0.0001).
CD45RA−CD15s+ (eTreg), as previously described (6).
The mean purity of the isolated populations was >95%.
Representative dot plots illustrating the FACSort gating strategy
(Figure 1B) and purity (Figure 1C) of each subpopulation are
shown. These purified cell populations were used for subsequent
methylation studies.
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In addition, a PBMC sample was stained with the same
antibody combination used for FACSort plus intracellular FoxP3.
When we analyzed the expression levels of FoxP3 within the
Treg subsets defined by CD45RA and CD15s expression, we
confirmed previous observations (6) that CD45RA+CD15s−
cells express the lowest, CD45RA−CD15s− cells intermediate
and CD45RA−CD15s+ cells the highest levels of FoxP3. This is
illustrated in a representative overlay of FoxP3 expression within
each of these Treg subpopulations, as well as within naïve Tcon
for comparison (Figure 1D). FoxP3 expression levels within Treg
subsets from all the donors analyzed are shown in Figure 1E.
Methylation of CAMTA1 Intronic Region
In cells of the immune system, including T and B cells,
Ca2+ signals are essential for diverse cellular functions
including proliferation, differentiation, effector function, gene
transcription, and apoptosis. The intracellular concentration
of Ca2+ is known to activate several signaling proteins and
transcription factors (TFs) such as calcineurin and NFAT, CaMK
and CREB, MEF2, and NFkB (17). Calcineurin–NFAT pathway is
involved in Treg development and function and is affected by the
absence of Ca2+ signals (18). It is, therefore, not coincidental that
one of the regions in CAMTA 1, a Ca2+ -dependent calmodulin-
binding transcription factor (19), was proposed as an additional
molecular marker distinguishing Treg from Tcon (7).
The methylation status of 13 CpG sites within the 470 bp
CAMTA1 intronic region 3 was assessed based on the top strand
of BS DNA (Supplementary Tables 1, 2). Two methylation
patterns were observed. In the first, represented by male
donor M4 (Figure 2B, left panel and Supplementary Table 3)
and comprising male donors M1-4 and female donor F2
(Figure 2C), the first eight CpG sites (CpGs 1-8) were more
demethylated in CD34+ cells and the three subsets of Treg as
compared to Tcon, as is evident from the average methylation
pattern (Figure 2B, lower panel).The average methylation
percentages for CpGs 1-8 in these donors were 37.8% (CD34+),
36.2% (CD45RA+CD15s−), 13.9% (CD45RA−CD15s−), and
35.8% (CD45RA−15s+) as compared to 74.1% in Tcon
(Supplementary Table 3). In the second pattern, represented
by donor F4 (Figure 2B, right panel) and comprising six
donors (M5, 6, and F1, 3-5), only two CpG positions were
consistently more demethylated in CD34+ cells and Treg
subsets as compared to Tcon. While in Tcon, CpGs 2
and 11 were 70 and 74.2% methylated, average methylation
levels of these two sites in the other four populations were
significantly lower: 25.8 and 33.3% (CD34+), 13.3 and 22.5%
(CD45RA+CD15s−), 10.8 and 16.7% (CD45RA−CD15s−), and
7.5 and 11.7% (CD45RA−CD15s+), respectively (Figure 2B,
right lower panel and Supplementary Table 3). Overall, the
entire CAMTA1 region in Tcon subset was heavily methylated
(80%) as presented by the average methylation pattern for eleven
donors (Figure 2C, lower panel and Supplementary Table 3),
however, the main differences were observed in CpGs 1-
11 (with the exception of CpG 9). Average methylation
levels for more demethylated CpGs 1-8 within the first
200 bp part of CAMTA1 region were 56.7% (CD34+),
49% (CD45RA+CD15s−), 41% (CD45RA−CD15s−), and 48%
(CD45RA−CD15s+) as compared to 78.4% in Tcon. CpG
sites 2 and 11 were more demethylated in CD34+ and Treg
subsets: 24.4, 20.5, 10, and 15% in CpG 2 and 36.3, 44.5,
27.7, and 33.6% in CpG11 in CD34+, CD45RA+CD15s−,
CD45RA−CD15s−, and CD45RA−CD15s+ cells, respectively,
as compared to 66.8 and 77.3% for these CpG positions in
Tcon (Supplementary Table 3). The differences in methylation
values for all CpGs were further analyzed using the function
lme from the package nlme of R and the calculated difference
was only considered as significant for those results with p
< 0.016. This analysis demonstrated significant differences
between all Treg subtypes compared to Tcon (p = 0.008 for
CD45RA+CD15s−, p = 0.0003 for CD45RA−CD15s−, and
p= 0.0004 for CD45RA−CD15s+).
Methylation of FUT7 Promoter
The induction of CD15s on human hematopoietic cells and
lymphocytes accompanies transcriptional activation of FUT7
which is involved in the last step of sialyl Lewis X synthesis
(12, 20). FUT7 is highly expressed in eTreg compared to
other FOXP3+ or FOXP3− subpopulations (5). Transcriptional
regulation of FUT7 plays an important role in lineage-specific
expression of CD15s among lymphocyte subpopulations. For
example, the generation of E-selectin ligands on T cells
undergoing naive-to-memory transition was shown to require
FUT7 activity (21). Human FUT7 promoter was demonstrated
to have binding sites for several TFs, six of which: T-bet,
GATA-3, Sp1, CBP/P300, HDAC-3, and HDAC-5 may form
transcriptional complex in human lymphoid cells (12, 20).
As FUT7 gene is encoded in the reverse strand of chromosome
9, FUT7 promoter region was amplified with the reverse strand-
specific primers (Supplementary Table 1). Due to the length
of this region and the fact that longer amplicons cannot be
successfully produced as a result of BS treatment, methylation
status of 19 individual CpGs was assessed within two amplicons,
500bp and 454bp in length, together comprising FUT7 promoter
(Supplementary Table 2). Methylation pattern within FUT7
promoter region was overall similar among donors M1-6 and
F1-3 and is represented by donor F3 (Figure 3B). Similar to
donor F3, CpGs 1-7 of other donors (with the exception of
CpG 5) did not show variations in methylation in all five cell
populations as demonstrated by the average methylation profile
of all donors (Figure 3C, lower panel). CpG positions 8-19
were mostly demethylated in CD34+ cells (with the exception
of CpG 13) with average methylation levels for the twelve
sites being 37.9% (CD34+), 54.1% (CD45RA−CD15s−), and
48.8% (CD45RA−CD15s+) as compared to CD45RA+CD15s−
(69.6%) and Tcon (75%). CpGs 10–12, 14, and 15 were
more demethylated in CD34+ (38.2%), CD45RA−CD15s−
(54.5%), and CD45RA−CD15s+ (45%) populations while
CD45RA+CD15s− and Tcon cells displayed higher methylation
levels (72.8 and 77.2%, respectively) (Figure 3C, lower panel, and
Supplementary Table 3). Overall, nTreg (CD45RA+CD15s−)
and Tcon subsets displayed a similar methylated pattern, while
CD45RA−CD15s−, eTreg (CD45RA−CD15s+) and CD34+
cells displayed a similar demethylated pattern, which was
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FIGURE 2 | Methylation pattern of CAMTA1 intronic region. CAMTA 1 intronic region is more demethylated in Treg subsets as compared to CD34+ cells and Tcon
within the 200 bp region containing CpGs 1-8. CpGs 2 and 11 are strikingly more demethylated in both Treg and CD34+ cells. (A) Schematic presentation of
CAMTA1 encoded on chromosome 1q3.6. (B) Two methylation patterns of CAMTA1 in five cell populations: CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s−
(3), CD45RA−CD15s+ (4), and Tcon (5) of representative donors M4 (pattern 1) and F4 (pattern 2). Average methylation percentages for donors following the two
patterns presented in panels below. CpGs 1-13 are numbered relative to the 5′-3′ direction of the coding (top) strand. Each horizontal line represents DNA from one
cell with unmodified C in light blue and mC in dark blue. Methylation percentage for each CpG site was calculated based on the number of mCs in a total of 20 and
summarized in panels below. (C) Methylation patterns of CAMTA1 intronic region of individual donors with the average methylation pattern for all donors presented in
the panel below. See also Supplementary Figures 1, 3.
characterized by hypomethylation of the five internal CpG sites:
10–12, 14, and 15 within the 225 bp region of FUT7 promoter.
In comparison to Tcon, the methylation values for all
CpGs within FUT7 region were significantly different for
CD45RA−CD15s+ (p = 0.0019) and CD45RA−CD15s− Treg
(p= 0.0098), but not for CD45RA+CD15s− Treg (p= 0.8889).
FOXP3 Enhancer
FOXP3 gene expression is dependent on the activity of several
regulatory DNA elements and our efforts were concentrated on
the four FOXP3 gene regions: enhancer, promoter, preTSDR
and TSDR, all of which were amplified with the reverse
strand-specific primers. Methylation data obtained from female
donors F1-5 is deliberately presented in its raw format, without
accounting for the possible Xi.
The FOXP3 enhancer is one of the three regulatory elements
in the FOXP3 locus that was shown to be controlled via
CpG methylation (9, 22). Located about 6 kb upstream of the
transcription start site (TSS), this 800 bp region is actually part
of a protein phosphatase 1 regulatory subunit locus. Methylation
pattern of the human FOXP3 enhancer was shown to be different
from that of its murine homolog (22), with both Treg and Tcon
populations of healthy donors displaying similar profiles. In
patients with arthritis, however, Treg subsets displayed higher
demethylation levels than in healthy donors (9), thus accounting
for greater differences in methylation between Treg and Tcon
cells in this disease setting.
Highly CpG rich FOXP3 enhancer contains over 50 CpG
positions.Methylation status of the first 42 CpG sites was assessed
in six donors (M1-4 and F1, 2). Because of limited blood sample
material, low gDNA quantity from rare Treg subsets and mostly
difficulties in cloning, determination of methylation status
within this region was not possible for other donors. Despite the
impressive number of CpG sites within the 497 bp amplicon, the
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FIGURE 3 | Methylation pattern of FUT7 promoter. CpG sites 10–12, 14, and 15 within FUT7 promoter display higher demethylation levels in CD34+ and effector
Treg as compared to naïve Treg and Tcon, indicating that CpGs 10-15 can be used as an additional molecular marker to distinguish these cell populations.
(A) Schematic presentation of FUT7 promoter encoded in the reverse strand of chromosome 9. (B) Methylation pattern of FUT7 promoter in five cell populations:
CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s− (3), CD45RA−CD15s+ (4), and Tcon (5) of representative donor F3. CpGs 1-19 are numbered relative to the
5′-3′ direction of the coding (reverse) strand. Each horizontal line represents DNA from one cell with unmodified C in light blue and mC in dark blue. Methylation
percentage for each CpG site was calculated based on the number of mCs in a total of 20 and summarized in the panel below. (C) Methylation patterns of FUT7
promoter of individual donors with the average methylation pattern for all donors presented in the panel below. See also Supplementary Figures 1, 3.
enhancer region demonstrated an intricate methylation pattern
represented by donor M4 (Figure 4B). Average methylation
levels for the most demethylated CpG sites 4, 9, 11, and 20 for
donor M4 were 11.2% (CD34+), 35% (CD45RA+CD15s−),
28.7% (CD45RA−CD15s−), 32.5% (CD45RA−CD15s+),
and 81.2% (Tcon) (Figure 4B and Supplementary Table 3).
Similar to this donor, CpG positions 1–3, 5–8, and 14–19
were mostly methylated in all cell populations of all donors
(Figure 4C). However, CpG positions 4, 9, 11, 20, and 24–28
demonstrated higher degree of demethylation in CD34+ cells
and Treg subtypes compared to Tcon as presented by the
average methylation pattern for this region (Figure 4C, lower
panel). Average methylation levels for CpGs 4, 9, 11, and 20 in
all donors were 27.6% (CD34+), 36.7% (CD45RA+CD15s−),
35.5% (CD45RA−CD15s−), 28.5% (CD45RA−CD15s+),
and 72.5% (Tcon) (Figure 4C, lower panel and
Supplementary Table 3).
Statistical analysis further confirmed significant differences
in methylation values for all CpGs within FOXP3 enhancer
for CD45RA+CD15s− (p < 0.00005), CD45RA−CD15s− Treg
(p = 0.0001), and CD45RA−CD15s+ (p = 0.0002), compared
to Tcon.
FOXP3 preTSDR
Not much is known about this region except that part of
it was more demethylated in CD25highCD45RA−CD4+ Treg
cells compared to CD25−CD45RA+CD4+ Tcon (Amp6/7) (7).
Considering the possibility of its hypomethylation in Treg
subtypes, it was also chosen for its proximity to TSDR.
Compared to Amp6/7, containing 7 CpG sites, preTSDR region
was extended to contain 10 CpG sites within 700 bp length
(Supplementary Tables 1, 2) and served as an additional internal
control for TSDR methylation boundaries as it is located
immediately upstream (hence the denomination we propose,
preTSDR).
Donors M2, 4, 5, and F4, 5 followed the pattern presented
for donor M6 (Figure 5B, left panel) whereby CpGs 2-4 were
heavily methylated in all five cell populations while various
degrees of demethylation were observed in CpGs 5, 8, and 9
(Figure 5C). As presented by the average methylation profile
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FIGURE 4 | Methylation pattern of FOXP3 enhancer. CpGs 4, 9, 11, 20, and 24–28 within FOXP3 enhancer are more demethylated in CD34+ cells and Treg subtypes
as compared to Tcon. (A) Schematic presentation of the FOXP3 enhancer encoded in the reverse strand of Xp11.23. (B) Methylation pattern of the FOXP3 enhancer
in five cell populations: CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s− (3), CD45RA−CD15s+ (4), and Tcon (5), of representative donor M4. CpGs 1-42 are
numbered relative to the 5′-3′ direction of the coding (reverse) strand. Each horizontal line represents DNA from one cell with unmodified C in light blue and mC in dark
blue. Methylation percentage for each CpG site was calculated based on the number of mCs in a total of 20 and summarized in panels below. (C) Methylation patterns
of the FOXP3 enhancer of individual donors with the average methylation pattern for all donors presented in the panel below. See also Supplementary Figures 1, 4.
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of all donors (Figure 5C, lower panel), these 3 sites were more
demethylated in CD34+ cells (19.6%) and two Treg subtypes:
CD45RA-CD15s- (25.9%) and CD45RA−CD15s+ (28.2%)
while Tcon (49.6%) and CD45RA+CD15s− subsets (43.3%)
displayed higher methylation levels (Supplementary Table 3).
In donor M6, the average methylation levels for these three
CpG sites were 10% (CD34+), 16.7% (CD45RA+CD15s−),
1.7% (CD45RA−CD15s−), 43.3% (CD45RA−CD15s+), and
76.7% (Tcon). Interestingly, more CpG sites throughout the
entire amplicon were demethylated in CD45RA+CD15s− and
CD45RA−CD15s− populations of female donor F3 (Figure 5B,
right panel), with average methylation levels for CpGs 1-10 being
33% for CD45RA+CD15s− and 47.5% for CD45RA−15s− as
compared to 91.5% for Tcon. This region-wide demethylation
was also present in CD34+ cells of donors F1 and F2, with
average methylation percentages for CpGs 1-10 being 9 and
11.5%, respectively. Compared to Tcon, statistically significant
differences in methylation values for all CpGs within FOXP3
preTSDR were observed for CD45RA−CD15s+ (p = 0.0087)
and CD45RA−CD15s− (p = 0.0004) Treg, but not for
CD45RA+CD15s− Treg (p= 0.2103).
FOXP3 Promoter and TSDR
Two regulatory regions in the FOXP3 locus, promoter and TSDR,
have been previously shown to be demethylated in thymically
derived nTreg and mostly methylated in induced Treg (iTreg)
and Tcon cells, both in mice and humans (7, 23–25). Several TFs,
such as NFAT, AP-1, Foxo1 and 3 bind to the FOXP3 promoter.
Some of these plus other TFs, such as CREB, NF-kB, Runx1,
STAT5, Gata3, Ets1, and FOXP3 itself interact with TSDR, with
CREB and NFAT, for example, in a demethylation-dependent
manner (23, 24, 26).
Methylation analysis of 10 CpG sites within 451 bp
region of FOXP3 promoter and 15 CpG sites within 700
bp region covering TSDR (Supplementary Tables 1, 2) from
the four T lymphocyte subsets of donor M1 (Figures 6B,E,
left panels) was in agreement with previously published
data demonstrating almost complete demethylation of these
regions in Treg subtypes and a high degree of methylation
in Tcon cells (Supplementary Table 3). With the exception
of CD45RA+CD15s− subset, which was heavily methylated
within TSDR and could account for individual differences,
donor M2 displayed similar methylation pattern in both
regions (Figures 6C,F). Average methylation levels for CpGs
1-10 within the promoter region of donors M1 and M2
were 9% (CD45RA+CD15s−), 1.7% (CD45RA−CD15s−), 7.5%
(CD45RA−CD15s+) and 58% (Tcon) (Figure 6B, left lower
panel), while for CpGs 1-15 within TSDR region they were
48.7% (CD45RA+CD15s−), 0.7% (CD45RA−CD15s−), 11.5%
(CD45RA−CD15s+), and 85.7% (Tcon) (Figure 6E, left lower
panel and Supplementary Table 3). However, promoter region
was demethylated (Figure 6C) and TSDR was methylated
(Figure 6F) in donors M3-6 and F1-5, without significant
differences between cell subsets and genders. Within the
promoter region, the average methylation levels for CpGs 1-
10 of these donors were below 1% for CD34+ cells and Treg
subtypes and slightly higher (6.6%) for Tcon (Figure 6C, lower
panel and Supplementary Table 3). Within TSDR, the average
methylation levels for CpGs 1-15 were close to 100% in all cell
populations (Figure 6F and Supplementary Table 3). Sequences
from the 700 bp TSDR region had an equally high level of non-
CpG conversion, indicating that mCs within CpG sites were
intrinsic to the analyzed region and were not the consequence
of incomplete conversion.
As expected, no significant differences in methylation within
FOXP3 promoter and TSDR were observed for any of the
Treg subtypes in relation to Tcon (p = 0.0401 and p = 0.1465
for CD45RA+CD15s−, p = 0.0438 and p = 0.1184 for
CD45RA−CD15s−, and p = 0.0408 and p = 0.1551 for
CD45RA−CD15s+ Treg, respectively for FOXP3 promoter and
TSDR).
Hierarchical Clustering
We applied an unbiased clustering method to examine
the distance of cell subtypes from each other based on
average CpG methylation for each genomic element
(Supplementary Figure 1). Hierarchical clustering shows
that methylation patterns for promoter, enhancer and TSDR
region of FOXP3 and CAMTA1 intronic region of Tcon cells are
farthest from all of the Treg subtypes, while for FOXP3 preTSDR
and FUT7 promoter methylation patterns show clustering of
Tcon cells with CD45RA+CD15s− Treg subtype. Clustering
on CpG positions for each genomic element further highlights
the positions with striking methylation differences across the
cell subtypes (Supplementary Figure 1). These CpG positions
with their average methylation observed across the four cell
populations are summarized in Figure 7.
Strand-Specific Methylation Biases Within
FOXP3 TSDR and Promoter
Previously observed methylation status of FOXP3 promoter
and TSDR of donors M3-6 and F1-5 was puzzling for several
reasons. First, no changes were introduced in terms of the work
flow (human factor, reagents, protocols). Second, all six gene
regions were amplified from the same batch of BS DNA from
each cell population. At the same time, the six gene regions
from the five cell populations were amplified from different
batches of DNA (one from each cell population). Third, preTSDR
region was intentionally introduced as an additional internal
control of both TSDR boundaries and efficiency of BS PCR:
the primers were designed in such a way as to produce 700
bp amplicons (Supplementary Table 1). Fourth, methylation
patterns of FOXP3 promoter and TSDR were similar in hundreds
of sequences analyzed (about 110 sequences per gene region
from each donor, over 1,000 sequences per gene region in total).
These reasons instilled great confidence in our data and led us
to consider the possibility that the observed methylation patterns
were intrinsic properties of the two regions of donors M3-6 and
F1-5.
To avoid any bias related to BS treatment and amplification,
a new batch of BS-treated DNA from donors M2, F1,
and F2 was used to detect methylation levels within TSDR
amplified either with two top strand-specific or both top and
reverse strand-specific primer sets (Supplementary Figure 2).
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FIGURE 5 | Methylation pattern of FOXP3 preTSDR region. CpG positions 1, 5, 8, and 9 within FOXP3 preTSDR show a certain degree of hypomethylation in CD34+
cells and Treg subtypes as compared to Tcon cells. (A) Schematic presentation of the FOXP3 preTSDR encoded in the reverse strand of Xp11.23. (B). Methylation
pattern of the FOXP3 preTSDR in five cell populations: CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s− (3), CD45RA−CD15s+ (4), and Tcon (5) of donors M6
and F3. CpGs 1-10 are numbered relative to the 5′-3′ direction of the coding (reverse) strand. Each horizontal line represents DNA from one cell with unmodified C in
light blue and mC in dark blue. Methylation percentage for each CpG site was calculated based on the number of mCs in a total of 20 and summarized in panels
below. (C) Methylation patterns of the FOXP3 preTSDR of individual donors with the average methylation pattern for all donors presented in the panel below. See also
Supplementary Figures 1, 4.
Previously obtained results for Treg and Tcon cells of donor
M2 as well as Tcon cells of donors F1 and F2 were confirmed
by the top strand-based data, however, the top strand-based
TSDR of donor F1 was now 60% and donor F2- 8.7-18.7%
methylated as compared to 100% methylation of the reverse
strand (Supplementary Figure 2 and Supplementary Table 3).
New batches of BS DNA from three cell populations:
CD45RA+CD15s−, CD45RA−CD15s+ and Tcon of donors
M4, M6, F3, and F4 for which we still had DNA available were
used to expand the strand-specific study which demonstrated
significant strand-bias methylation within TSDR region. Overall,
the reverse strand of TSDR remained 100% methylated in the
three cell subsets in donors of both genders (Figure 8A, lower
panels denoted RS) while methylation pattern of the top strand
(Figure 8A, top panels denoted TS) changed depending on the
cell population and gender (Supplementary Table 3). Despite
gender differences, similar patterns in the top strand of TSDR
were observed in donors M4 and F3 with average methylation
levels for CpGs 1-15 being 0 and 1.3% (CD45RA+CD15s−),
0 and 2% (CD45RA−CD15s+), and 97.3 and 93.3% (Tcon),
respectively. The top strand of TSDR in CD45RA+CD15s−
subset of donor M6 was completely demethylated, followed by
CD45RA−CD15s+ cells (62%) and Tcon (99.3%). Donor F4
displayed similar methylation levels within the top strand in both
CD45RA−CD15s+ and Tcon (94.7 and 91.3%, respectively),
while CD45RA+CD15s− subset was 44.7% methylated which
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FIGURE 6 | Methylation patterns of the FOXP3 promoter and TSDR. FOXP3 TSDR region is methylated within the coding (reverse) strand while promoter remains
demethylated in several donors of both genders. (A,D) Schematic presentation of the FOXP3 promoter (A) and TSDR (D) encoded in the reverse strand of Xp11.23.
(B) and (E). Methylation patterns of the FOXP3 promoter (B) and TSDR (E) in five cell populations: CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s− (3),
CD45RA−CD15s+ (4), and Tcon (5) of representative donors M1 (B,E) and M4 and F2 (B,E). Average methylation percentages for the donors following methylation
patterns of the presented donors are summarized in panels below each representative donor. CpGs 1-10 (promoter) and 1-15 (TSDR) are numbered relative to the
5′-3′ direction of the coding (reverse) strand. Each horizontal line represents DNA from one cell with unmodified C in light blue and mC in dark blue. Methylation
percentage for each CpG site was calculated based on the number of mCs in a total of 20 and summarized in panels below. (C,F) Methylation patterns of the FOXP3
promoter (C) and TSDR (F) of individual donors with the average methylation pattern for all donors presented in panels below. See also Supplementary Figures 1, 6.
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FIGURE 7 | Hierarchical clustering of Tcon and Treg (CD45RA+CD15s−,
CD45RA−CD15s−, and CD45RA−CD15s+) subtypes based on average
methylation. CpG positions with striking methylation differences across the cell
subtypes were further analyzed after an unbiased clustering method examining
the distance of cell subtypes from each other based on average CpG
methylation for each genomic element (see also Supplementary Figure 1).
Each row corresponds to CpG positions for each genomic element.
would be consistent with Xi. Interestingly, methylation
patterns of female donors F2 (Supplementary Figure 2) and F3
(Figure 8A) were not consistent with Xi as their Treg subsets
displayed nearly complete demethylation in the top strand: 8.7%
in CD45RA+15s− of donor F2, 1.3% in CD45RA+15s− and 2%
in CD45RA−15s+ of donor F3 while the reverse strand remained
100% methylated (Supplementary Table 3). Statistical analysis
demonstrated a highly significant difference in methylation
for all CpGs within top strand as compared to the reverse
strand for CD45RA+CD15s− Treg (p = 6.15E-07), but not for
CD45RA−CD15s+ Treg (p= 0.026091).
With these findings in mind, we proceeded to investigate
the possibility of strand-bias methylation within the FOXP3
promoter region. BS DNA from Treg and Tcon populations
of donors M6, F3, and F4 from the previous experiment
was used to amplify FOXP3 promoter with top strand- and
reverse strand-specific primer sets (Supplementary Tables 1, 2).
Confirming our previous results, all 10 CpG sites in the
reverse strand of Tcon cells from “unconventional” donors M6
and F4 were 0% methylated (RS in Figure 8B, lower panel
and Supplementary Table 3). However, methylation pattern
of the top strand was now different and in agreement
with “conventional” methylation of FOXP3 promoter in
Tcon cells, with average methylation levels of 84 and 64%
(M6 and F4, respectively). Average methylation levels in
CD45RA+CD15s− subsets were 5% (donor M6) and 48%
(donor F4). Data from donor F3 additionally confirmed
the top-strand bias methylation pattern, with the average
methylation levels of 63% in CD45RA+CD15s− subset and
72% in Tcon (Supplementary Table 3). Interestingly, CpG
site 6 was completely demethylated in donor F4 in both
CD45RA+CD15s− and Tcon subsets. Similar to female donor
F1 (Supplementary Figure 2), donor F4 displayed a pattern that
would be consistent with Xi in both top-strand based TSDR
(Figure 8A) and promoter (Figure 8B) which was not evident in
donors F2 (Supplementary Figure 2) and F3 (Figure 8A).
DISCUSSION
Gene expression in a fast-paced environment of physiological
responses is controlled by a complex of distinct regulatory
elements: promoters, enhancers, silencers, and insulators, which
are defined by functional boundaries of the locus. Both
epigenetic mechanisms, such as DNA hypomethylation, histone
modifications, non-coding RNAs, and nucleosome positioning,
and FOXP3 induction control stable gene expression in Treg
cells (7, 8, 27). Treg-specific genes, such as Ikzf2 and Ikzf4,
seem to be dependent on Treg-specific DNA hypomethylation,
tend to be up-regulated in stable suppressive Treg cells and
are independent of FOXP3 expression. FOXP3 itself seems to
mainly act as a repressor which down-regulates the expression
of its target genes in eTreg cells (28). DNA demethylation of
both FOXP3 promoter and TSDR regions was demonstrated to
be important for FOXP3 expression and nTreg development,
lineage commitment and suppressive phenotype (8), while
FOXP3 stability can be influenced by microRNAs (miRNAs) and
ubiquitination. Impairment of miRNA function was shown to
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FIGURE 8 | Strand-specific methylation bias within the FOXP3 TSDR and promoter regions. Treg TSDR region in some donors is characterized by a complete
methylation of the coding (reverse) strand and a significant demethylation of its complement template (top) strand. (A) Methylation patterns of the top (TS) and reverse
(RS) strands within FOXP3 TSDR in CD45RA+CD15s−, CD45RA−CD15s+ and Tcon cells of “unconventional” donors M4, M6, F3, and F4. CpGs 1-15 are numbered
relative to the 5′-3′ direction of the coding (reverse) strand. (B). Methylation patterns of the TS and RS within FOXP3 promoter in CD45RA+CD15s− and Tcon cells of
“unconventional” donors M6 and F4. CpGs 1-10 are numbered relative to the 5′-3′ direction of the coding strand (RS). Each horizontal line represents DNA from one
cell with unmodified C in light blue and mC in dark blue. Methylation percentage for each CpG site was calculated based on the number of mCs in a total of 10 and
summarized in panels below. See also Supplementary Figure 2.
downregulate FOXP3 expression in Treg, induce inflammatory
cytokines, and result in the development of systemic AID in mice
(2). Inflammatory conditions also trigger the ubiquitination and
degradation of FOXP3, which can dampen Treg function without
affecting FOXP3 expression (29).
In this study, the epigenetic status of CAMTA1
intronic region, FUT7 promoter and four FOXP3 gene
regions was characterized in CD34+ hematopoietic
stem cells and four populations of CD4+CD25+
T cells: CD45RA+CD15s−FOXP3low (nTregs),
CD45RA−15s−FOXP3low (non-suppressive Treg-like cells),
CD45RA−CD15s+FOXP3high (eTregs), and Tcons isolated from
peripheral blood of healthy male and female donors.
Firstly, we demonstrated a complex methylation pattern
of CAMTA1 intronic region and FUT7 promoter. CpG sites
10–12, 14, and 15 within FUT7 promoter displayed higher
demethylation levels in CD34+ and eTreg as compared to nTreg
and Tcon (Figure 3, Supplementary Figure 1) indicating that
the middle 225 bp part of FUT7 promoter (CpGs 10-15) can
be used as an additional molecular marker to distinguish eTreg
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from nTreg and Tcon. Overall, CAMTA 1 intronic region was
more demethylated in Treg subsets as compared to CD34+
cells and Tcon within the 200 bp region containing CpGs 1-8
(Figure 2, Supplementary Figure 1). However, CpGs 2 and 11
were strikingly more demethylated in both Treg and CD34+
cells. Hypomethylation of certain CpGs in some cell populations
but not others indicates that these sites can play essential roles
for TF binding and control of gene expression depending on
the immediate demands of the environment. TFs induce or
repress gene transcription by either promoting or hindering
the accessibility of regulatory elements to proteins of the
transcription initiation complex. It is, therefore, not coincidental
that our search for TF binding sites using PROMO software (30)
revealed several very interesting potential candidates binding to
or within immediate vicinity of the hypomethylated sites on
FUT7 and CAMTA1 gene regions. Of greatest relevance would
be FOXP3 itself, YY1, TFII-I, GR, and GATA1 predicted to bind
CAMTA1 and FOXP3, C/EBPα, TFII-I, cEts, and GRα predicted
to bind FUT7 promoter (Supplementary Figure 3).
Secondly, we characterized methylation patterns of the
four FOXP3 regions. Our experimental methodology allowed
for a more precise characterization of individual sites within
FOXP3 enhancer than the one previously reported (9). CpGs
4, 9, 11, 20, and 24–28 were more demethylated in CD34+
cells and Treg subtypes as compared to Tcon (Figure 4,
Supplementary Figure 1). PreTSDR region was chosen for its
immediate proximity to TSDR and CpG positions 1, 5, 8,
and 9 demonstrated certain degree of hypomethylation in
CD34+ cells and Treg subtypes as compared to Tcon cells
(Figure 5, Supplementary Figure 1). The hypomethylated CpGs
were predicted to be part of the recognition sequences of several
relevant TFs. FOXP3 itself, C/EBPα, RARα, STAT4, and TFII-I
were predicted to bind preTSDR, while GRα, LEF-1, TCF-4E and
TFII-I - FOXP3 enhancer (Supplementary Figure 4).
Fascinatingly, CD34+ cells exhibited an “nTreg-like
epigenome” in all studied gene regions except for FUT7
promoter which was demethylated unlike nTreg subset. Analysis
of FOXP3, CD15s, and CD45RA expression demonstrated that
CD34+ population does not express FOXP3, is heterogeneous
and comprised of a nearly equal number of CD15s− (also
CD45RA−) and CD15s+ cells which, in turn, consist of
two subtypes: CD15s+CD45RA− and CD15s+CD45RA+
(Supplementary Figure 5).
Thirdly, we report unexpected methylation patterns of FOXP3
promoter and TSDR in several donors.While our data for donors
M1 and M2 is in agreement with previously published studies
(5, 7) demonstrating demethylation of both regions in Treg cells
and methylation in Tcon, the strand-specific methylation biases
observed in donors M3-6 and F1-5 have not been reported
previously. TSDR region was characterized by a complete
methylation of the coding (reverse) strand and a variable
methylation of its complement template (top) strand (Figures 6,
8) which followed the previously reported “conventional” pattern
whereby TSDR region ismostly demethylated in nTregs, becomes
more methylated in eTregs and is mostly methylated in Tcons.
Data for preTSDR region (Figure 5) determined the boundary
of biased methylation. As for the FOXP3 promoter, the opposite
was observed: the coding strand was completely demethylated in
CD34+ cells and all T lymphocyte subsets (Figure 6C) while the
template strand followed “conventional” pattern whereby it was
demethylated in nTreg and methylated in Tcon cells (Figure 8B).
CpG positions are usually expected to be either fully
methylated or fully demethylated in both DNA strands, therefore,
there should not be a “right” or “wrong” strand when choosing
to study conventional methylation patterns and data obtained
from one strand can be safely assumed to apply to the second
strand. Still, the phenomenon of strand-specific methylation has
been described both in mammalian and plant DNA (31–33). For
example, Singal and Vanwert (32) demonstrated that methylation
of the template (reverse) strand of the avian embryonic r-globin
gene promoter and proximal transcribed regions lags behind that
of the coding (top) strand, and complete methylation of both
strands occurs only after the gene has been silenced.
Many studies in both mice and humans demonstrated
correlation of demethylation of the FOXP3 promoter and TSDR
regions with stable protein expression, while their methylation
was suggested to be characteristic of iTregs which lack FOXP3
(7, 25). FOXP3 expression and TSDR demethylation have
been widely used as prognostic markers for determining the
proportion of Treg cells in peripheral blood from healthy
individuals and in certain diseases such as ovary, breast and
colorectal cancers and other solid tumors (34, 35). In some
diseases, TSDR was shown to become methylated in Treg cells or
demethylated in non-Treg cells (36, 37). Some studies, however,
published conflicting reports demonstrating that demethylation
of promoter and TSDR was not always coupled with FOXP3
expression. For example, Bailey-Bucktrout et al. (38) showed that
murine Treg with demethylated TSDR down-regulated FOXP3
transcription in the inflamed CNS, while Bending et al. (39)
revealed that demethylation of these regions was decoupled from
stable FOXP3 expression in a subset of CD4+CD127lowCD25hi
human T cells that were increased in the more severe forms of
arthritis.
We attempted to clarify the matter of strand specificity within
FOXP3 locus by checking about 90 published articles. Our
conclusions, to the best of our abilities, are based on either
primer sequences provided in the article or reference contained
within the article (which led to the original primer sequences).
Studies that did not have any information on either were later
excluded from the database (Supplementary Table 4). While
human and murine FOXP3 genes are highly conserved, they
are encoded on different strands of X chromosome. Therefore,
data obtained from the reverse (coding) strand of human FOXP3
gene should be compared to the top (coding) strand of murine
FOXP3, and vice versa for the template strands. Out of 61
studies, 27 on human TSDR and 8 on promoter were based on
the top (template) strand, while only 6 on human TSDR were
based on the reverse (coding) strand. Eight studies on murine
FOXP3 TSDR were top strand-based and six—reverse strand-
based. Some studies used different strands to assess methylation
of different regions, different methods, or different donors. For
example, Baron et al. (7) used human top strand for TSDR
(Amp5) and one half of the enhancer region (Amp11), and
reverse strand for preTSDR (Amp6) and the second half of the
Frontiers in Immunology | www.frontiersin.org 14 November 2018 | Volume 9 | Article 2540
Minskaia et al. Epigenetics T Cell Subtypes
enhancer (Amp 10). Kennedy et al. (9) used human top strand
for TSDR and reverse strand for promoter and enhancer. In
addition, five studies on human TSDR used BS cloning - three
were RS-based (5, 37, 40) and two were TS-based (39, 41),
while the rest used pyrosequencing, methylation-sensitive qPCR
(MS-qPCR) and methylation-sensitive single-nucleotide primer
extension (MS-SNuPE). For example, Baron et al. (7) used MS-
SNuPE detecting one CpG on the TS to study differences in Treg
and Tcon populations between 3 donors of both genders. Two
studies (37, 42) used RS of human TSDR for BS sequencing and
TS for MS-qPCR, and Bailey-Bucktrout et al. (38) used murine
RS for MS-qPCR and TS for BS sequencing. In addition, it is
important to point out the differences in cellular markers used to
define Treg populations: in most studies, Treg subset was defined
as CD4+CD25+ (42), CD4+CD25highCD127low (9, 34, 35, 39),
and even CD25highCD45RA− (7) or, instead, melanoma cell lines
were used (37), while our study further dissects Treg population
into three Treg subsets.
Our RS-based data for donors M1 and M2, as well as the
TS-based data for donors M3-6 and F1-5 is in agreement with
previously published studies. As all donors in this study were
chosen randomly and presented in the order they were processed,
it is impossible to speculate on whether this “unconventional”
methylation pattern may in fact be prevalent (as in our random
selection) or was a matter of good/bad luck. It does, however,
appear possible that donors with either methylation pattern exist.
The novel strand-bias methylation pattern may be perceived as
“decoupling”—whereby Treg subtypes express FOXP3 protein
yet possess methylated TSDR (based on RS only).
Several very important TFs, including AP-1, NFAT, CREB,
NF-kB, Runx1, STAT5, Gata3, Foxo1 and 3, Ets1, and FOXP3,
have been implicated in the transcriptional control of Treg
cell differentiation, and both promoter and TSDR regions are,
to various degrees, essential for this (23, 24, 26). Yet, the
mechanisms that initiate the demethylation of TSDR remain
poorly understood. While it was shown that CREB/ATF, NF-κB,
Ets-1, and FOXP3/Runx1/CBFβ protein complexes bind TSDR
in a demethylation-dependent manner (8, 43), these studies used
in vitro systems that used dsDNA constructs and enzymes that
methylate both DNA strands.
While recognition of binding sequences by TFs is very
important, the ability to interact with other TFs or regulatory
proteins is an essential part of DNA-binding specificity.
However, binding orientation may not be that important in
affecting TF function (44) and it remains to be investigated
whether demethylation-dependent TFs are capable of binding
hemimethylated DNA. Many TFs are predicted to bind CpG-
containing recognition sequences on both DNA strands within
FOXP3 TSDR (Supplementary Figure 6). It is tempting to
speculate that either the ability to bind hemimethylated DNA
will be completely inhibited or TFs will recognize their binding
sequences on both strands and be redirected from the coding
strand containing mC to the template, demethylated strand,
which may potentially change the direction of transcription
and result in the production of antisense RNAs. Even more
fascinating is the fact that several TFs are predicted to contain
a C in the recognition sequence on one strand but not the other.
It is possible that FOXP3 (CpG1), GRα (CpG3), and Pax-5/p53
(CpG 15) containing mC within their recognition sequences on
the RS may choose instead to bind the TS that does not contain
a C, while STAT4 and TFII-I (CpG10) that do not contain a C on
the RS will be able to bind either strand.
While the RS within TSDR is completely methylated, it is
completely demethylated within promoter in all cell populations
(Figure 8A). This could have evolved as a compensatory
epigenetic mechanism and demonstrates that transcription
within FOXP3 locus is not affected (as also confirmed by FOXP3
expression in Treg subsets in this study). Promoters usually
remain demethylated to allow for initiation of transcription
(which is blocked by methylation). Methylation within intronic
regions (like FOXP3 TSDR), however, is a feature of transcribed
genes that often occurs in a tissue-specific manner, possibly
stimulates transcription elongation and may result in alternative
splicing (45). Intergenic regions of human Treg cells were
found to possess TSS clusters confirmed to be either antisense
transcripts or splicing variants of Treg signature genes, such as
FOXP3 and Ctla4 (46), and FOXP3 TSDR region contains several
species of antisense RNA transcripts which play important roles
in FOXP3 induction and stability (8, 28).
It is also possible that what we observed in the reverse
strand of TSDR region in Treg subsets is not methylation but
hydroxymethylation which plays important roles in regulation
of gene expression. Epigenetic changes in FOXP3 locus (based
on murine coding strand) were shown to be closely connected
via methylcytosine dioxygenase 2 (Tet2), down-regulation of
which prevented TSDR demethylation (47). Tet2 deficiency
also results in impaired differentiation of hematopoietic stem
cells and developed autoimmune phenotypes in murine models
(48). Nestor et al. (49) reported early and widespread active
enzymatic 5mC/5hmC remodeling (enriched in the regulatory
regions of FOXP3) in the absence of replication during human
CD4+ T cell differentiation. Presence of 5hmC was suggested
to be intermediate during conversion of transcriptionally
repressive 5mC to transcriptionally permissive unmodified
cytosine. However, It would be impossible to detect 5hmCs
using our methodology, as both cytosine modifications present
themselves as mCs after BS treatment.
Last but not least, methylation patterns of the four regions
on the FOXP3 locus were often surprisingly similar in donors
of both genders, therefore, we deliberately presented our data
from female donors in its raw format and did not simply
account for Xi characteristic of X-linked genes in females. At
least 15% of genes in women and only 3% in mice escape
Xi due to distinct differences between murine and human X
chromosomes—the murine X only has one long arm with a
centromere at the end while the human X has two arms: the
short (Xp) and the long (Xq), with centromere in between.
The inactivation process initiating from the murine Xi can
easily spread throughout the length of the chromosome and is
more complete (50, 51). While some X-linked genes are stably
inactivated or stably escape Xi, other genes display variable levels
of expression from Xi (50) and can be observed among cells
within a tissue, over time during development and between
individuals enhancing phenotypic differences (51). Interestingly,
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female naïve and activated lymphocytes do not maintain Xi with
the same fidelity as other somatic cells and are predisposed
to become partially reactivated and to overexpress immunity-
related genes (50, 52). Therefore, it is possible that silencing
at the FOXP3 locus is incomplete and leaky Xi may take
place. In addition, eighteen X-linked miRNAs were shown to
be overexpressed in CD4+ T cells of women with lupus, five of
those—in experimentally demethylated CD4+ T cells suggesting
that demethylation contributed to the escape of Xi. Several other
female biased miRNAs potentially regulate FOXP3 expression
with some miRNA binding sites located in 3′ UTR of FOXP3
transcript (53).
To conclude, the findings in this study suggest that
hypomethylated CpG sites, present in four regions of the FOXP3
locus, CAMTA1 and FUT7 gene regions, can potentially be used
to distinguish subsets of CD4+ T lymphocytes in both sexes.
With the exception of FUT7 promoter, these CpG sites also define
CD34+ cells as having a “naïve Treg-like epigenome” that do not,
however, express FOXP3 protein.
We also describe previously unreported strand-bias
hemimethylation pattern within the human FOXP3 promoter
and TSDR in some donors of both genders. The coding strand
is demethylated within the promoter and methylated within the
TSDR in all of the CD4+ cell subtypes, whilst the template strand
follows the “conventional” methylation pattern.
These data provide new insights into the epigenetic control
of CD4+ T lymphocytes. FOXP3 expression and TSDR
demethylation are classically used for confirmation of Treg
lineage commitment and differentiation status, and for
prognostic purposes in various disease settings. While the
effect of the described hemimethylation pattern on Treg function
will become the subject of a new study, our findings suggest that
the strand-specific approach can be instrumental in disclosing
potential differences between subsets of Treg and Tcon. The
strand-bias methylation findings challenge current simplified
interpretations of TSDR methylation as a Treg marker since top
strand-based TSDR-demethylated cells may be reverse-strand
TSDR-methylated.
In light of our results, we propose that it is essential, to (i)
obtain the TSDR coding reverse-strand methylation data first,
(ii) further clarify the precise TSDR methylation pattern of both
strands, and /or (iii) use CAMTA1 or FUT7 levels of methylation
as additional molecular markers to clearly distinguish subsets of
Treg from Tcon.
Finally, our findings will directly impact both on Treg research
and on the clinical application of Treg-related therapies and
prognostics in the fields of autoimmunity, allergy and cancer.
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